Cargando…
Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL(3)B
BACKGROUND: The high rate of mortality due to malaria and the worldwide distribution of parasite resistance to the commonly used antimalarial drugs chloroquine and pyrimethamine emphasize the urgent need for the development of new antimalarial drugs. An alternative approach to the long and uncertain...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213633/ https://www.ncbi.nlm.nih.gov/pubmed/17956613 http://dx.doi.org/10.1186/1472-6904-7-13 |